Angiogenesis Modulators Market Research Report

Abstract

This report gives an insight into the types of Angiogenesis Modulators — Inhibitors and Stimulators — and their impact on various diseases. Business profiles of 25 major companies are discussed in the report. The report serves as a guide to the global angiogenesis industry, covering more than 490 companies engaged in angiogenesis research, testing and supply of products and services. Major Contract Research Organizations and Universities serving the angiogenesis industry are also covered in the corporate directory section. Information related to product developments, partnerships, collaborations, mergers and acquisitions is also covered.

Highlights

Global angiogenesis therapeutic products market is projected to grow at 25% compounded annually from 2010 through 2022. Growth is driven by aging and growing populations, cardiovascular disease and continued oncology research. Both natural and synthetic angiogenesis inhibitors are under development for Oncology, Central Nervous System, Dermatology and Ophthalmology applications.

Why buy this report

This report may help strategists, investors, laboratories, contract research organizations, biotechnology and healthcare companies, academic professionals, drug approval authorities and other organizations to

• Identify market opportunities
• Review and analyze global and regional markets
• Gauge market potential for your products
• Identify competition
• Acquire meaningful guidelines for strategic planning
• Gear up for market entry
• Get actionable information

Chapters

1. Scope and MethodologyResearch methodology, limitations, market measuring units and exchange rates used.
2. Report SynopsisGlobal Angiogenesis Modulators market by therapeutic products including Inhibitors and Stimulators, disease areas and regional markets.
3. Market DynamicsGlobal and regional markets by disease area and modulator across North America, Europe, Asia-Pacific and Rest of World, with cancer demographics, trends and outlook.
4. Competitor DynamicsProfiles of major global companies and corporate activities including mergers and acquisitions, partnerships and new product developments.
5. Product/Technology ResearchDefinitions, segmentation, applications, disease mechanisms, product trends, potential opportunities and research activity.
6. Corporate DirectoryA region-wise list of companies, CROs and academic institutions engaged in Angiogenesis Modulator products and services.
7. Patents InformationWorldwide patents related to Angiogenesis products, services and technologies.

Table of contents

• Scope and Methodology
• Report Synopsis
• Market Dynamics
• Regional Analysis
• Product/Technology Research
• Competitor Dynamics
• Corporate Directory
• Patents Information

The full table of contents and list of exhibits come with the sample pages. Request sample pages.

Choose a licence

Reports are delivered as a PDF by email within one working day of payment. Payment by PayPal or by invoice. Read the licence terms and terms of sale.